---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-274135"
form_type: "8-K"
ticker: "OM"
cik: "0001484612"
company_name: "Outset Medical, Inc."
filed_at: "2026-06-17T20:05:17+00:00"
generated_at: "2026-06-17T20:11:55.379644+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Outset Medical secures ~$40M HCA commitment for Tablo hemodialysis system refresh through 2028

## Summary
- HCA commits to purchase new Tablo hemodialysis consoles from 2026 through 2028 under Refresh Amendment; aggregate contract value ~$40M net of rebates.
- Term extended to Dec 31, 2028; existing consoles traded in for credit; HCA cannot terminate for convenience during refresh.
- Outset reiterates 2026 financial guidance; expects to provide more detail on deal's 2026 impact later this year.
- Amendment includes rebates, uptime guarantees, and support service fee terms; certain pricing details redacted as confidential.

## SEC filing metadata
- accession: 0001193125-26-274135
- form_type: 8-K
- ticker: OM
- cik: 0001484612
- company_name: Outset Medical, Inc.
- filed_at: 2026-06-17T20:05:17+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484612/000119312526274135/0001193125-26-274135-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484612/000119312526274135/om-20260614.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-274135
- JSON: https://secwatch.observer/filing/0001193125-26-274135.json
- Plain text: https://secwatch.observer/filing/0001193125-26-274135.txt

## Key facts
- Earnings Releases
  Outset Medical, Inc. updated its 2026 guidance (reaffirmed).
  - Period: 2026
  - Guidance: reaffirmed
  - Result: guidance update
  source text: The Company is reiterating previously issued guidance for 2026, and plans to provide additional detail regarding the 2026 financial impact of the Amendment later in the year once it has visibility to the timing and ramp of the implementation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484612/000119312526274135/0001193125-26-274135-index.htm
- Material Agreements
  Outset Medical, Inc. amended Refresh Amendment with HCA Management Services, L.P. valued at approximately $40 million (effective 2026-06-14).
  - Action: amendment
  - Agreement: supply
  - Counterparty: HCA Management Services, L.P.
  - Value: approximately $40 million
  - Effective: 2026-06-14
  source text: On June 14, 2026, Outset Medical, Inc., (the “Company”) entered into the Refresh Amendment (the “Amendment”) to the Purchasing Agreement with HCA Management Services, L.P. (“HCA”), dated May 1, 2020, as amended (collectively, the “Agreement”). Under the terms of the Amendment, the parties have agreed, among other things, for HCA to refresh its existing fleet of Tablo Hemodialysis Systems by purchasing new Tablo Hemodialysis Systems commencing in 2026 through the end of 2028, for an aggregate contract value, net of rebates and allowances, of approximately $40 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484612/000119312526274135/0001193125-26-274135-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.